止痛调经方治疗原发性痛经(寒凝血瘀型)的临床研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
目的:探讨止痛调经方治疗寒凝血瘀型原发性痛经(Primary dysmenorrhea,PD)的临床疗效及作用机制。方法:将50例属于寒凝血瘀型原发性痛经的患者随机分为止痛调经方组(治疗组)和少腹逐瘀胶囊组(对照组)各25例,比较两组用药前后的中医症状疗效、疼痛疗效、盆腔血流阻力、搏动指数、雌激素(E_2)、孕激素(P)等相关指标的变化。结果:在中医证候疗效方面,治疗组总有效率为96%,对照组总有效率为72%,两组比较有显著性差异(P<0.01)。在疼痛疗效方面,治疗组明显优于对照组,两组比较有统计学意义(P<0.05)。治疗组疗后盆腔血流阻力指数、搏动指数疗效优于对照组(P<0.05),治疗后治疗组较对照组E_2含量下降明显(P<0.05),P含量上升,两组比较差异有显著性(P<0.01)。结论:止痛调经方能够有效改善痛经患者的临床症状和体征,提高临床疗效;能改善盆腔血循环,减少子宫动脉血流阻力,调节卵巢激素水平,改善内环境。
Objective: To investigate clinical efficacy and mechanism of action the treatment of blood stasis type caused by cold accumulation Primary Dysmenorrheal.Methods: 50 cases of the patients with blood stasis type caused by cold accumulation primary dysmenorrhea were randomly divided into Pain-relieving and regulating menstruation formula. treatment group (treatment group) 25 cases and shaofuzhuyu Capsule (control group) of the 25 cases.Before and after medication,the therapeutic effects on PD ,TCM symdroms, pelvic blood flow resistance index changes in related indicators,and the E_2、P were compared. Results: In the aspect of comprehensive curative effect the TCM symdroms of the Treatment group was 96%, the control group was72%, the two groups which were compared with had significant difference (P <0.05). in the aspect of pain Syndromes'effect, the treatment group was significantly better than the control group (P <0.05). The two groups which were compared with had significant difference (P <0.05) in the aspect of RI、PI curative effect,the treatment group was significantly better than the control group (P <0.05). The E_2 level of treatment group obviously decreased(P <0.05).The P level of treatment group obviously increased(P <0.01).Conclusion: Pain-relieving and regulating menstruation formula can effectively improve the clinical symptoms and signs of the PD'patients, improve the clinical efficacy; improve pelvic blood circulation.reduce uterine artery resistance and the homeostatic equilibrium of organism and consolidate curative effect
引文
[1]乐杰.妇产科学.北京:人民卫生出版社,2004,347.
    [2]张玉珍.中医妇科学.北京:中国中医药出版社,2005,124-12.
    [3]中华人民共和国卫生部.中药新药临床研究指导原则.1993,263-266.
    [4]曹泽毅.中华妇产科学2版.北京:人民卫生出版社,2004,2482-2483.
    [5]韩蓁.原发性痛经病因研究进展,国外医学妇幼保健分册,1997,8(1);1-2.
    [6]王瑞霞.原发性痛经患者外周血T淋巴细胞亚群的研究.实用妇产科杂志,2004,20(4):229-230.
    [7]IzzoA,etal.ClinExpObstetGy-necol,1991;18(2):109-116.
    [8]张明发,沈雅琴.肉桂的药理作用及温里功效.陕西中医,1995;16(1):39-42.
    [9]张明发,苏晓玲,沈雅琴.干姜现代药理研究概述.中国中医药科技,1996;3(2):46-49.
    [10]张翠兰,文德鉴.当归对血液及造血系统药理作用研究进展.湖北民族学院学报.医学版,2002;19(4):34-36.
    [11]夏泉,张平,李绍平.当归的药理作用研究进展.时珍国医国药,2004;15(3):164-166.
    [12]凌学静,张海石,黄岩.西红花对小鼠免疫增强作用的研究.中国中医基础医学杂志,1998,4(12):28-2912.
    [13]OstadN.EvaluationofimpactFoeniculumvulgarevarietydulceoninhibitingthe contractionsofratsuterusinducedbyoxytocinandprostaglandinE2.Barijess encepamphlet,2000,(1):27-29.
    [14]李庆林,创桂新,窦昌贵等.乌药提取物的镇痛抗炎作用研究.中药材,1997,20(2):629.
    [15]沈建芬,肖军花,王嘉陵.当归A3活性部位的抗炎作用及其对大鼠离体子宫环氧化酶-2表达的影响.中草药,2006:37(9):1371-1374.
    [16]许建中,沈小珩,许得盛等.沪产西红花60例慢性疾病患者免疫调节作用的临床观察.上海中医药杂志,1998,32(1):32-33.
    [17]LinMTeta.lTheprotectivesffectofdl-tetrahydropalmatineagainstthedevelo pmentofamygdalekindlingseizuresinrats.NeurosciLett,2002;320(3):113.
    [18]黄泰康.常用中药成分与药理手册.北京:中国医药科技出版社,1994;879-881.
    [19]GuptaMB.IndianJMedRes,1971;59(1):76.
    [20]三川潮.国外医学中医中药分册,1984,(4):22.
    [21]刘国卿,等中国药科大学学报,1989,20(1):48.
    [22]张发初等.中华医学杂志,1935;12:1351.
    [23]王世久,宋丽艳,刘玉兰等.五灵脂乙酸乙酯提取物抗炎作用研究.沈阳药学院学报,1994:11(1):49-52.
    [24]王世久,刘玉兰,宋丽艳等.五灵脂抗血小板聚集作用的药理研究.沈阳药学院学报,1994:11(4):246-249.
    [25]吴函子.白芍的药理研究与临床研究.中国医院药学杂志,1998,18(4):172-173.
    [26]谢玲,杨凌红,李晓惠.当归药理作用研究进展.中医药研究,2000:16(6):56-58.
    [27]张晓萍.川芎及其有效成分药理活性研究进展.黑龙江医药,2005,18(5):332-333.
    [28]王雅君,刘宏鸣,李吉.桃仁抑制血小板聚集作用的研究.上海医药,1998,19(3):27-28.
    [29]陈琼,顾仁樾,周端.藏红花对冠心病心绞痛患者血流变学的作用.辽宁中医杂志,1997,24(8):372-373.
    [30]欧长兴,丁家欣,张玲.1126种中药抗凝血酶作用的实验观察.中草药,1987,18(4):21.
    [31]IevinJHetal.FertilSteril,1992,58:530-536.
    [32]黄荷凤,何赛男.子宫前列腺素研究进展.国外医学,妇产科学分册,1995,22(5):265-268.
    [33]CameronRetal.Prostaglandins,1991,42:155-157.
    [1]王应兰.痛经辨治浅谈.江苏中医,1995,16(11):40.
    [2]李祥云.痛经治疗当分虚实.上海中医药报,2002-09-28(002).
    [3]肖统海,孙彩侠.痛经分年龄段辨治举偶.安徽中医学院学报,1995,24(2):38-39.
    [4]陈国华.痛经的辩证与治疗.民族医药报,2008-5-9(003).
    [5]齐津丽.辨证治疗原发性痛经60例.辽宁中医杂志,2006;33(3):323.
    [6]匡继林.谢剑南教授辨证化瘀法治疗原发性痛经经验.湖南中医药导报,2002;8(9):548-551.
    [7]董克玲.近15年来中医治疗痛经方药应用分析.国医论坛,2003;18(3):50.
    [8]邓海霞.王采文治疗原发性痛经特色探析.中国中医药信息杂志,2001;8(5):71.
    [9]王霞灵,曹大农等.艾附暖宫汤为主治疗痛经的临床研究.中医药学刊,2003;2(5):668.
    [10]江伟华,叶美玲.补肾化瘀方治疗痛经121例.上海中医药杂志,2003;37(5):44-45.
    [11]刘书婷.妇乐汤治疗痛经患者60例临床观察.中国中西医结合杂志,2006;26(5):430.
    [12]王学凤.少腹逐瘀汤加减治疗痛经70例临床观察.甘肃中医,2006;19(6):30-31.
    [13]郑纯.痛经停冲剂治疗寒凝血瘀型痛经60例临床观察.中医杂志,2002;43 (10):761-762.
    [14]史建辉,殷炯辉,靳全友等.痛经宁治疗原发性痛经的临床研究.河北中医,2003;25(4),250-253.
    [15]陈磊,潘碧琦,陆强益,等.血府逐瘀口服液治疗原发性痛经临床观察.吉林中医药,2006;26(5):22-24.
    [16]杨援朝.痛经片治疗功能性痛经115例.陕西中医函授,2000;4:15-16.
    [17]李占勋.针灸辨证分型治疗痛经.中国针灸,2002;22(2):108.
    [18]张忆平.针刺中冲治疗痛经.中国针灸,2002;22(9):612.
    [19]樊琴.痛经片配合针刺治疗原发性痛经50例临床观察.河北中医,2007;29(8):713.
    [20]何文扬.温针治疗痛经.中国针灸,2002,22(2):108.
    [21]张华玉.隔姜灸神阙穴治疗痛经.中国针灸,2002,22(3):194.
    [22]于云,王培安.痛经膏外贴治疗痛经80例.中医外治杂志,2004,5:46.
    [23]刘卫平.中药外敷治疗寒凝血瘀型原发性痛经45例疗效观察.中医外治杂志,2004:13(4):4-5.
    [24]周丽蓉.腹舒粘敷贴治疗痛经187例.上海中医药杂志,2003;37(4):36-37.
    [25]刘国兰.脐疗针灸法治疗原发性痛经100例.现代医药卫生,2003;19(7):504.
    [26]田葱,黄慧霞,赵慧萍等.痛经暖脐散治疗原发性痛经61例.现代中西医结合杂志,2002,11(17):1694-695.
    [27]高贵生,高晓峰.痛经的辨证按摩治疗.按摩与导引,2005,21(4):41.
    [28]汪明德,李香萍.痛经宁栓剂治疗原发性痛经的临床研究.中国中医药科技,2008,15(1):52-53.
    [29]郭李燕,陈秀廉,钱志益.痛经膏外耳道给药治疗原发性痛经26例疗效观察.新中医,2002,34(7):19-20.
    [30]王敏.穴位注射治疗痛经100例疗效观察.云南中医中药杂志,2002,23(3):28.
    [31]张金艳,曹永孝,刘静等.痛经宁胶囊对雌性幼鼠生殖器官发育的影响及其镇痛抗炎作用.中成药,2004,26(7):571-573.
    [32]宋卓敏,屈彩芹,张远等.痛经宁颗粒对痛经大鼠子宫雌、孕激素受体的影响.中华中医药杂志,2006,21(1):35-38.
    [33]张会常,冯勤喜,于春艳等.痛经平抗痛经的实验研究.中医药学刊,2005,23(2):244-245.
    [34]孟楠,周金秋,吴宜艳等.痛经舒对家兔血液流变学指标的影响.牡丹江医学院学报,2006,27(2):20-21.